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DURING the last 25 years, several reports on the frequency ratio of malignant
neoplasms among the African people have appeared from different parts of the
African Continent (Pirie, 1921 ; Smith and Elmes, 1934; Strachan, 1934;
Berman, 1935; Vint, 1935; des Ligneris, 1936; Prates, 1938; Elmes and
Baldwin, 1947; Gelfand, 1948; Davies, 1948; Findlay, 1949; Higginson, 1951;
Thijs, 1957; Wainwright, 1957). Apart from the study on liver cancer and
cirrhosis (Prates, 1938), up to the present no information has been forthcoming
concerning the cancer frequency ratios in Africans living in the Portuguese
province of Mozambique on the East Coast of Africa.
Through the generous assistance of the National Cancer Association of South
Africa, a cancer survey unit was established inLourengo Marques almost two years
ago in order to ascertain the risk to cancer for the African population in and
around Louren,o Marques. As an essential preliminary to the main survey all
the histological material collected in the pathological laboratory during the
previous 13 years was analysed. It was hoped that such a preliminary analysis
might indicate the kinds of cancers to be expected in this city.
In view of the limited medical services and the paucity of cancer registries in
the underdeveloped Continent ofAfrica, the greatest amount ofinformation about
cancer in Africa will continue to be derived, in the immediate future, from post-
mortem and hospital statistics. Although these statistics cannot allow any pre-
dictions to be made about the risk to cancer for the population as a whole, never-
theless, a comparison ofthe data accumulated inthe hospital at Louren9o Marques
over the last 13 years with the preliminary data of the rates survey conducted
over a period of 19 months, will afford some indication of the site frequency of
certain types of cancers and the potential value which can be attached to the data
derived from conventional routine services of pathological laboratories and
hospitals in regions where special cancer units and registries are still not available.
Accordingly, it is proposed:
1. To report the kinds of cancers and their frequency ratios in all the
material collected in Louren9o Marques during the past 13 years,
2. to compare these date with those accumulated during the 19-month
period following the establishment of the Cancer Unit when interest in
cancer was greatly stimulated, and
3. to compare the data from Louren9o Marques with those available
from other territories in Africa. From this comparison, it will become
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* apparent that although there are some similarities, there ate &iso marked
differences in the site frequency of cancer in different parts of Africa
suggesting that environmental influences may be operating in predisposing
some sites to cancer more than others.
MATERIAL AND METHODS
The Province of Mozambique is situated between longitude 300 and 42' East
and latitude 100 and 27° South and covers 297,731 square miles (771,255 square
kilometres). According to the census of 1950, the population comprises 5,647,000
Africans (2,692,863 males and 2,954,137 females); 50,000 Europeans; 26,000
Coloureds; and 15,000 Asiatics. The medical service, including hospitalisation,
is provided free for all Africans, for all the other racial groups earning a salary of
less than £30 per month and for all civil servants.
TABLE I.-The Number of In-patients and Out-patients of the
Lourengo Marques Hospitalfor the Year 1956
In-patieW8t
Europeans . . 3,263
Africans . . 13,246
Coloured . . 1,258
Total . . 17,767
Out-patients
Europeans . 26,374
Africans . . 47,560
Coloured . . 7,629
Total . . 81,563
The largest hospital in the Province is located in Louren,o Marques and has
about 1000 beds for Africans. The in-patients' turnover in 1956 was 13,246
Africans, 3263 Europeans and 1258 Coloureds and Asiatics. Of the female in-
patients 5230 were admitted to the maternity wards. If allowance is made for
maternity cases, then three-quarters of the in-patients are males, and only one-
quarter females.
47,560 Africans, 26,374 Europeans, and 7629 Coloureds and Asiatics sought
treatment in the outpatients' department during 1956 (Table I). It should be
mentioned that all the pathological material from Mozambique is sent to the
hospital " Miguel Bombarda " (Lourengo Morques' hospital) for examination.
The greatest number ofexaminations are conducted for in-patients as well as out-
patients in the Louren9o Marques Hospital, and, to a lesser extent, for patients
distributed widely throughout the entire province. It follows that the greatest
number of cancers are derived from patients treated in and around Lourengo
Marques. The material as a whole is more representative of the peopleinhabiting
the South than of those living in the Central and Northern regions.
The rates survey is being conducted on a population of African people num-
bering approximately 100,000, living in the city and environs ofLourengo Marques.
Prior to the middle of 1956, a total of 1606 malignant neoplasms was diagnosed
from autopsy and histological examination. In May 1956, the special survey was
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initiated. During the past 19 months, a total of 371 malignant tumours was diag-
nosed by autopsy and histological examination. Tumours diagnosed by any other
method, e.g. radiological or clinical, are not considered in the present study. Of
the total of 371 tumours, 210 were found in patients not belonging to the popu-
lation ofLouren9o Marques under survey. That is to say, three groups ofmaterial
were accumulated; the first from 1944 to 1956; the second obtained from all
cancer patients seeking treatment at the Lourenco Marques Hospital from May
1956 to December 1957; while the third group included patients with malignant
neoplasmsbelongingstrictly to the area under surveyfrom May 1956 to December
1957, inclusive. The total number oftumours recorded in Africans from May 1944
to December 31, 1957 was 1273. In addition, 580 tumours were identified in
Europeans and 124 tumours in Coloureds and Asiatics making a total of 1977
malignant neoplasms.
RESULTS
Table II summarizes the distribution by sex and race of 1977 malignant
tumours accumulated over a period of 13 years, and diagnosed at autopsy and by
histological examination. Of these tumours 580 were derived from Europeans,
1273 from Africans and 124 from the other races.
Amongst the European males, 303 malignant neoplasms were found. The skin
accounted for 30-0 per cent of all tumours and thereafter, in order of frequency,
the stomach for 8-9 per cent, the large intestine and rectum together for 8-9 per
cent and malignancies of lymphoid tissue (8-9 per cent) and larynx and lung
(9.5 per cent) (Table III). Amongst the European females, 23-8 per cent of all
carcinomas occurred in the breast, 24-8 per cent in the cervix and the uterus and
15X1 per cent in the skin. That is to say, in females, 63-7 per cent of all cancers
were obtained from the breast, uterus (including the cervix) and skin. The ratio
of carcinoma of the body of the uterus to carcinoma of the cervix in European
women was 1: 4-6. Three Kaposi tumours were diagnosed in Europeans, two in
males and one in a female. One chorionepithelioma, two gliomata of the brain,
one glioma ofthe eye, three sarcomata ofthe connective tissue and bone and two
lymphosarcomata occurred in Europeans under the age of 20 years. Breast
carcinoma and carcinoma ofthe body ofthe uterus and skin cancer did not appear
in European women in Lourengo Marques under the age of 20 years (Table II).
As far as the Africans are concerned, it is evident from Table II that ofa total
of842malignantneoplasms amongst males, 43 -1 per cent wereprimaryintheliver.
Liver cancer, therefore, was at least three times as common as any other tumour.
The skin (13.9 per cent), the lymphatic tumours (8.6 per cent) and the bladder
(7 9 per cent) were next inorderoffrequency. Cancers ofthesefoursites accounted
for 73-6 per cent ofall cancers in African males as compared with 40 5 per cent for
the same sites in European males. Carcinoma of the stomach (1-0 per cent), of
the oesophagus (0.4 per cent), colon (0.3 per cent), rectum (0.1 per cent) as well as
carcinoma of the larynx (0.2 per cent), lung and bronchus (0.3 per cent) occurred
less frequently in the African male than comparable tumours in the European
male.
Amongst the African females, carcinoma of the cervix uteri (20-6 per cent),
carcinoma of the liver (14.6 per cent), carcinoma of the skin (13.9 per cent) and
carcinoma of the bladder (7.2 per cent) comprised 56*3 per cent of all cancers, as
compared with 36.6 per cent for tumours in comparable sites in European females.
179180 M. D. PRATES
In the African female, the relative frequency ratio of carcinoma ofthe breast was
7-4 per cent as compared with 23*8 per cent in the European female. The ratio of
carcinoma ofthe corpus uteri to carcinoma ofthe cervix uteri was 1: 18 in African
womenas comparedwith 1: 4-6 inEuropeanwomen. One caseofKaposi's sarcoma
was found in an African female as compared with 22 in African males.
TABLE II.-Distribution of All Malignant Neoplams by Site, Type and Age in Europeans
and Africans from April 1944-December 31, 1957
Age groups
1- 10- 20- 30- 40- 50- Over
Type Race Sex 10 20 30 40 50 60 60 ?
Ca. . Eur. . M. . 0 1 0 0 1 0 5 1
F. . 0 0 0 0 0 0 0 0
Afr. . M. . 0 1 1 0 1 0 0 0
F. . 0 0 3 0 2 0 2 0
Grand
b Total Total Coloured
8 }
3 18
I 7J
141 . Tongue . Ca., 10
Sarcoma, 1
142.1 . Salivary . Ca.
gland
Parotid
144 . Mouth . Ca.
145A . Tonsil . Ca.
146 . Naso-pharynx.
150 Oesophagus
151 . Stomach
152C . Small
intestine
153A . Large
intestine
. Eur. . M. 0
. F. . 0
. Afr. . M. . 0
F. . 0
. Eur. . M. . 0
F. . 0
Afr. . M. . 0
F. . 0
. Eur. . M. . 0
F. . 0
Afr. . M. . 0
F. . 0
. Eur. . M. . 0
F. . 0
Afr. . M. . 0
F. . 0
Ca. . Eur. . M. 0
F. . 0
Afr. M. . 0
F. . 0
Ca. . Eur. . M. . 0
F. . 0
Afr. . M. . 0
F. . 0
Ca. . Eur. . M. . 0
F. . 0
Afr. . M. . 0
F. . 0
Ca. . Eur. . M. . 0
F. . 0
Afr. . M. . O
F. . 0
Ca. . Eur. . M. . 0
F. . 0
Afr. . M. O
F. . 0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
0
0
0
0
0
0
0
0
0
1
1
0
0
0
0
1
0
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
0
0
0
1
0
0
0
0
0
0
0
0
0
0 1
0 0
0 0
0 0
0 0
0 0
1 0
1 1
0 0
0 0
1 5
4 4
0
0
0
0
0
0
0
0
0
0
0
0
2
1
0
0
0
1
0
0
1
1
1
0
0
0
2
0
1
0
0
0
0
1
1
0
9
6
2
0
0
1
1
0
1
1
2
0
2
0
3
0
0
0
0
2
1
1
3
0
1
0
1
0
1
1
0
0
1
0
0
0
2
0
0
0
0
0
0
1
2
0
3
0
1
0
0
0
0
0
0
0
0
0
1
0
6 10
5 1
2 4
0 0
0 2
0 1
0 0
1 0
5 9
1 2
0 0
0 0
0
0
0
0
0
0
0
0
1
0
1
1
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
No.
Int.
Nom.
140
Site
Lip
5
4 9 + 2
4°S6 + 1
4 3
4 6 + 2
1
1 } 49 + 3
7 2
10 26 + 5
2
1 3
17
16 , 6 + 2
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TABLE II-cont.
Age groups
_ K o~~~~~~A
1- 10- 20- 30- 40- 50-Over
Type Race Sex 10 20 30 40 50 60 60
154 . Rectum
155 . Liver . Ca. Primary
155C . Gall bladder
157 . Pancreas
158 . Abdominal .
cavity
160A . Nose
161 . Larynx
162B . Lung
162C . Bronchus
170 Breast
171 . Cervix uteri .
172 . Corpus uteri .
173 . Uterus
Ca. . Eur. . M. . 0 0 0
F. . 0 0 0
Afr. . M. . 0 0 0
F. . 0 0 0
. Eur. . M. . 0 0 0
F. . 0 0 0
Afr. . M. . 2 67 113
F. . 1 7 21
Ca. . Eur. . M. . 0
F. . 0
Afr. . M. 0
F. . 0
Ca. . Eur. . M. 0
F. . 0
Afr. . M. . 0
F. 0
Ca. . Eur. . M. . 0
F. . 0
Afr. . M. . 0
F. . 0
Ca. . Eur. . M. . 0
F. . 0
Afr. . M. . 0
F. . 0
Ca. . Eur. . M. . 0
F. . 0
Afr. . M. . 0
F. . 0
Ca. . Eur. M. . 0
F. . 0
Afr. . M. . 0
F. . 0
Ca. . Eur. M. 0
F. 0
Afr. . M. . 0
F. . 0
Ca. . Eur. M. 0
F. . 0
Afr. . M. . 0
F. 0
Ca., 21 . Eur. . M. 0
Sarcoma, 2 . F. . 0
Afr. . M. . 0
F. . 0
Chorion- . Eur. . M. . 0
epithelioma F. . 0
Afr. . M. 0
F. 0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
83
16
0
1
1
0
0
0
3
0
00
00
10
1 1
00
00
01
00
01
01
00
00
00
00
00
00
00
3 12
00
36
0 2
0 1
0 1
0 3
4 1
0 2
53 26
7 5
0
0
0
0
1
0
3
0
0
0
0
0
0
0
0
0
1
0
2
0
3
0
0
0
0
22
1
9
2
3
0
0
1
0
1
0
2
1
1
0
2
0
0
0
5
0
0
0
3
1
0
0
0
18
0
6
7
1
0
0
3
1
15
5
2
2
0
0
0
0
1
1
0
2
1
1
0
0
0
0
7
0
0
0
7
0
3
0
0
8
0
7
0 0 0 0 0
0 11 20 14 9
0 0 0 0 0
9 18 28 20 10
0 0 0 0 0
2 1 1 4 5
0 0 0 0 0
0 1 1 1 0
0 0 0 0 0
0 6 2 0 0
0 0 0 0 0
2 0 0 0 0
Grand
? Total Total Coloured
I 10 +
0 2 16 +
0 3J
0
0
4
1
0
1
0
0
1
0
0
0
0
0
0
0
0
0
0
0
1
0
0
0
1
0
0
0
0
3
0
1
0
1
0
4
0
1
0
1
0
1
0
0
8
3 437
363 J
63J
4
7 12
1 3 )
0 12 8
2
3 11
3
2
O 3
15
2 18
14
3 18
616 99
32
+ 6
+ 2
+ 2
+ 1
+ 2
+ 2
+ 12
0
50 144 + 21
89 J
14
18 + 5
4 J
10 12 + 4
2J
No.
Int.
Nom. SiteM. D. PRATES
TABLE I1-cont.
Age groups
,1
A
1- 10- 20- 30- 40- 50-Over
Type Race Sex 10 20 30 40 50 60 60
Ca. . Eur. . M. . 0 0 0 0 0 0 0
F. . 0 0 2 2 0 5 0
Afr. . M. . 0 0 0 0 0 0 0
F. . 0 1 0 2 0 1 1
Grand
? Total Total Coloured
0 O
0 9 14
0 O
0 5
176 . Vagina
177 . Prostate
178 . Testes
179A . Scrotum
179B . Penis
Ca. . Eur. . M. . 0
F. . 0
Afr. . M. . 0
F. . 0
Ca. . Eur. . M. . 0
F. . 0
Afr. . M. . 0
F. . 0
Various . Eur. . M. . 0
neoplasms F. . 0
Afr. . M. . 0
F. . 0
Ca. . Eur. . M. . 0
F. . O
Afr. . M. . 0
F. . 0
Ca. . Eur. . M. . 0
F. . 0
Afr. . M. . 0
F. . 0
180 . Kidney . Various . Eur. . M. . 0
neoplasms F. . 0
Afr. . M. . 1
F. . 1
181A . Bladder
190 . Skin
191A
191B
191D
Ca. . Eur. . M. . 0
F. . 0
Afr. . M. . 0
F. . 0
Melano- . Eur. . M. . 0
blastoma F. . 0
Afr. . M. 0
F. . 0
PI . Basal cell ca.
Other ca.
Eur. . M. . 0
F. . O 0
Afr. . M. . 1
F. . 0
,,9 . Kaposi's . Eur. . M. . 0
tumour F. . 0
Afr. . M. . 0
F. . 0
192A . Eye Glioma . Eur. M. . 0
F. . 1
Afr. . M. . 3
F. . 2
0
0
0
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
1
0
0
0
0
4
0
0
0
0
1
0
0
0
0
0
0
0
0
0
1
0
0 0
0 0
1 1
0 0
0
0
0
3
0
0
1
0
1
0
1
0
1
0
1
0
0
0
5
0
0
0
1
2
0
2
0
7
0
0
1
0
1
0
0
0
0
0
0
0
0
0
12
0
0
0
0 0 0 1
0 0 1 0
0 8 16 23
0 2 8 8
0 0 0 0
0 0 0 1
0 2 1 7
0 1 2 1
0 3 5 20
0 0 2 6
6 12 15 26
2 7 9 15
0 0 2 0
0 0 0 0
2 2 3 5
0 0 0 0
0 0 0 0
0 0 0 0
0 0 0 0
O 00 0
0
2
0
4
6
0
2
0
1
0
0
0
0
0
1
0
1
0
5
0
2
1
0
0
0
0
9
6
0
0
2
0
0
1
0
5
4
0
6
0
0
0
0
0
0
0
0
0
1
0
3
0
0
0
0
0
2
1
9
6
0
1
3
4
23 32
13 15
12 4
3 13
0 0
1 0
7 2
0 1
0 0
0 1
0 0
0 0
0
1
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
2
0
0
0
0
0
0
0
2
1
0
0
1
2
6
3
3
0
0
0
1
0
0
0
0
0
6 30
24
10
1 20 + 2
O J
1
3 2°
2
29 31 + 4
3
2 12 + 2
3
3
67 }103 + 7
31J
2 28
10J
89
39 256 + 9
49
2
21 !26 12
7
No.
Int.
Nom.
175A
Site
Ovary
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TABLE II-cont.
Age groups
r A- I
1- 10- 20- 30- 40- 50 Over
Race Sex 10 20 30 40 50 60 60 ?
. Eur. . M. . 0 1 0 0 1 0 0 1
F. . 0 0 0 0 0 0 0 0
Afr. . M. . 1 2 3 5 2 1 0 0
F. . 3 0 3 4 4 1 2 0
Grand
Total Total Coloured
3 }
14 (34 + 1
17J
193A . Brain
194 . Thyroid
gland
196 . Jawbone
196C . Other bones
197 . Connective .
tissue
Glioma . -Eur. . M. . 2
F. . 0
Afr. . M. 2
F. . 1
Ca. . Eur. . M. . 0
F. . 0
Afr. M. . 0
F. . 0
Various . Eur. . M. . 0
neoplasms . F. . 0
Afr. . M. . 0
F. . 0
Sarcoma . Eur. M. . 0
F. . 0
Afr. . M. . 1
F. . 0
Sarcoma . Eur. M. . 1
F. . 0
Afr. . M. . 3
F. . 2
198 . Lymph nodes . Secondary:
Ca. Sarcoma
200.0 . Various
sites
200.1 . Ditto
201 Lymph
nodes
203
204B
204E
Eur. . M. . 0
F. . 0
Afr. . M. . 0
F. . 0
Reticulum . Eur. . M. . 0
cell . F. . 1
sarcoma . Afr. . M. . 3
F. . 3
Lympho- . Eur. . M. . 2
sarcoma F. . 0
Afr. . M. . 10
F. . 6
Hodgkin's Eur. . M. . 0
disease F. . 0
Afr. . M. . 0
F. . 0
0
0
4
0
0
0
1
0
0
0
6
1
1
0
2
0
1
0
7
2
0
0
2
0
0
0
0
0
0
0
4
3
1
1
7
1
0
.0
3
0
1
0
2
2
2
0
1
2
0
0
3
1
1
2
9
2
0
0
5
0
.0
0
0
1
0
0
3
2
4
3
9
1
0
0
3
0
0
0
0
1
0
0
3
4
0
0
2
1
3
4
9
4
1
1
1
1
0
2
0
0
1
0
4
2
1
1
9
1
2
0
2
1
0
1
0
2
1
0
1
1
0
0
0
0
2
3
9
3
1
0
2
1
0
0
1
0
2
0
3
1
3
0
6
2
1
0
0
0
0
0
0
1
0
0
0
0
1
0
0
0
1
1
4
2
2
1
2
0
1
0
0
0
1
0
2
1
1
0
2
2
0
0
0
0
0
0
0
0
0
1
0
0
0
0
1
0
3
2
0
5
1
2
1
1
0
0
0
3
0
0
2
0
1
1
1
2
0
0
0
0
0
0
0
0
1
0
0
0
0
0
0
1
0
3
0
1
0
1
0
0
0
1
0
0
0
0
0
2
0
0
0
8
.0(
14 }24
2J
10
1
11
3
6
3
12 k2
8 J
2
°8 13
3J
10
46 F8
15J
10
15 S3
3J
2
35 14
4J
9
2°0 52
17J
12
36 60
34
+ 1
+2
+6
+2
+ 2
+ 3
+6
Various . Myeloma .Eur. .M.. 0 0 0 1 0 0 0 0 1
sites Lymphatic F. .0 0 0 0 0 0 0 0 0 13 and myeloid Afr.. M. .1 1 0 5 1 0 00 8
leukaemia F.. 0 0 0 1 1 1 1 0 4 J
Totals . Eur. . M. 5 6 13 20 57 76 106 20 303
F. . 2 3 12 48 68 76 56 12 277
Afr. . M. . 28 115 182 176 174 87 61 19 842
F. . 19 18 67 92 99 60 65 11 431
Eur.-European.
Afr.-African.
No.
Int.
Nom.
192C
Site
Eye
183
Type
Various
neoplasmsM. D. PRATES
TABLE III.-Distribution by Site, Type and Sex, of all Malignant Neoplasms in Europeans,
Africans and Coloureds* from April 1944-December 31, 1957
No.
Int.
Nom. Site
140 Lip
141 Tongue
142. 1 Salivary
gland parotid
144 Mouth
145A Tonsil
146 Nasopharynx
150 Oesophagus
151 Stomach
152C Small
instestine
153A Large
intestine
154 Rectum
155A Liver
155C Gall bladder
157 Pancreas
158 Abdominal
cavity
160A Nose
161 Larynx
162C Lung
Bronchus
170 Breast
171 Cervix uteri
172 Corpus uteri
173 Uterus
175A Ovary
176 Vagina
177 Prostate
178 Testes
179A Scrotum
179B Penis
180 Kidney
181A Bladder
190 Skin
191A
191D
191D
192A
192C
193A
194
Eye
1,,
Brain
Thyroid
gland
Type
Ca.
Sarcoma
Ca.
Sarcoma
Ca.
Sarcoma
Ca.
Carcinoid
Ca.
Ca. (Primary)
Ca.
Sarc.
Chorion-
epithelioma
Ca.
Semmoma
Sarcoma
Ca.
Various
neoplasms
Ca.
Melano-
blastoma
Basal cell Ca.
Other ca.
Kaposi's
tumour
Glioma
Various
neoplasmns
Ditto
Ca.
196 Jawbone Adamantinoma
Sarcoma
1960 Other bones Sarcoma
197 Connective ,.
tissue
Per-
centage
European African Coloured of all
A neo-
M. /% F. 0 AI. % F. % . M F. Total plasms
8 2-64 0 0 3 0-36 7 1-62 0 0 18 0-91
5 1-65 0 0 4 0-47 0 0 1
° 11 0-56 0 0 0 0 00 0 0 0 lf
1 0-33 0 0 0 0 5 1-16 1 8 0-40
0 0 0 0 1 0-12 0 0 0
0
4 1-32 1 0-36 12 l-54 8 2-1 1 0 28 1-42
0 0 0 0 if0 l 0 0 -
3 0-99 0 0 3 0-36 0 0 2 OJ 8 0-40
2 0-66 1 0-36 0 0 0 0 0 0 3 0-15
1 0-33 1 0-36 4 0-47 0 0 2 0 8 0-40
27 8191 13 4-7 9 1-06 0 0 2 1 52 2-63
2 0-66 3 1-08 1 0-12 1 0-23 0 0 7 035
15 5 3 ~0-3 0 0 0 1 1 2 5-61 15} 2-17 0 0-36 0 0 0
1 31 1-57
10 3-31 2 0-72 1 0-12 3 0-70 1 3 20 1-02
8 2-64 3 1-09 363 43-11 63 14-62 5 1 443 22-42
4 1-32 7 2-51 1 0-12 0 0 1 1 14 0-70
3 0.99 0 0 8 0-95 1 0-23 1 1 14 0-70
2 0-66 3 1-09 3 0-36 3 0-70 0 1 12 0-61
2 0-66 0 0 1 0-12 0 0 0 0 3 0-15
15 4-95 1 0-36 2 0-24 0 0 2 0 20 1-02
14 4-62 1 0-36 3 0-36 0 0 1 1 20 1-02
0 0 66 23-83 1 0-12 32 7-42 0 12 111 5-61
0 0 55 19-87 0 0 89 20-65 0 21 165 8-36
0 0
13 5-05 0 0 4 0-93 0 31 22 1-11
0 0 lj 0 0 OJ 0 lj
0 0 10 3-6 0 0 2 0-46 0 4 16 0-81
0 0 9 3-25 0 0 5 1-16 0 0 14 0-70
0 0 6 2-17 0 0 24 5-57 0 0 30 1-52
10 3-31 0 0 10 1-2 0 0 2 0 22 1-11
2} 1-32 0 0 1 0-12 0 0 0 0-25
1 0-33 0 0 2 0-24 0 0 0 0 3 0-15
2 0-66 0 0 29 3-44 0 0 4 0 35 1-77
3 0-99 2 0-72 4 0-47 3 0-70 0 2 14 0-70
3 0-99 2 0-72 67 7-96 31 7-19 7 0 110 5-56
0 0 2 0-72 16 1-9 10 2-3 0 0 28 1-42
73 24-08 32 11-55 14 1-66 15 3-48 5 1 140 7-09
16 5-27 7 2-51 65 7-72 34 7-89 2 1 125 6-33
2 0-66 1 0-36 22 2-61 1 0-23 0 0 26 1-32
0 0 2 0-72 3 0-36 2 0-46 0 0 7 0-35
3 0-99 0 0 14 1-66 17 3-94 0 1 35 1-77
8 2-64 0 0 14 1-66 2 0-46 0 0 24 1-21
1 0-33 1 0-36 3 0-36 6 1-4 1 0 12 0-61
1 0-99 1 0-36 5 1-43 4 1-86 0 0 24 1-21
2 0-66 0 0 8 0-95 3 0-70 2 0 15 0-76
10 3-31 13 4-7 46 5-46 15 3-48 2 4 90 4-55
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TABLE III-cont.
Per-
centage
No. European African Coloured of all
Int. o-],^Aneo-
Nom. Site Type M. % F. % M. % F. % M. F. Total plasms
198 Lymph Secondary ca. 9 3-31 2} 109 14}178 3 0°70 1 1 33 167 nodes Sarcoma If I Ij 0 0 0 Oj
200.0 Various Reticulum 2 0-66 3 1-09 5 0-59 4 0-93 1 1 16 0-81
sites cell sarcoma
200.1 Ditto Lympho- 9 2 97 0 0 26 3-08 17 3 94 3 0 55 2-78
sarcoma
201 Lymph Hodgkin's 12 3*95 6 2-17 34 4 04 8 1 86 3 3 66 3-34
nodes disease
203 Bones Myeloma 1 0-33 0 0 2 0 24 1 0 23 0 0 4 020
204B Blood Lymphatic 0 0 0 0 0 0 3 0 70 1 0 4 0 20
leukaemia
204A ,, Myeloid 0 0 0 0 6 0-71 0 0 0 0 6 0 30
leukaemia
Totals 303 100 277 100 842 100 431 100 57 67 1977 100
* As a total of only 124 neoplasms were observed amongst Coloured peoples, the percentage frequency of these
tumours has not been included.
From this analysis, several trends in the tumour ratio frequency can be recog-
nized in Louren9o Marques, namely,
1. A predilection of cancer for the liver in African males and females
as compared with the European;
2. carcinoma of the cervix uteri is relatively more frequent than car-
cinoma of the corpus uteri in African as compared with European women;
3. breast carcinoma appears to be less common in African than in
European women;
4. skin cancer in the European male is more common than in the
African male although the types of skin tumours developed by the two
races are not the same;
5. carcinoma ofthe lung, oesophagus, stomach, large bowel and rectum
are relatively uncommon in the African as compared with the European
(Table II).
Data for the Indian, Chinese and Coloured groups are too limited for analysis
and are merely included in Table II as additionalinformation on tumourfrequency.
Preliminary information from our rates survey discloses that only a small
percentage of Africans live beyond the age of 65 years. The age structure of the
population may influence profoundly the site incidence of cancer. Nevertheless,
one fact is outstanding, namely, that as far as liver cancer is concerned, it occurs
with unusual frequency under the age of 40 years (Table VI). Of a total of 363
cases of primary carcinoma of the liver in males, no less than 182 occurred under
the age of30years while infemales, 29 of63 were present under the age of30years.
It may well be that when corrected for the age distribution of the population,
carcinoma of the liver may increase still further with age. But, at present, the
early development of liver carcinoma in young people cannot be disputed.
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TABLE IV.-Primary Carcinoma of the Liver, by Race, Sex and Age
No. Age groups
Int. A
Nom. Site Type Race Sex 1-10 10-20 20-30 30-40 40-50 50-60 Over 60 ? Total
155a .Liver .Carcinoma European .M. .0 0 0 0 4 1 3 0. 8
(Primary) F. .0 0 0 0 0 2 1 0. 3
African . M. . 2 67 113 83 53 26 15 4 363
F. . 1 7 21 16 7 5 5 1 63
Coloured .M. 1 0 0 2 0 1 1 0. 5
F. . 0 1 0 0 0 0 0 0 .
Total . 4 75 134 101 64 35 25 5 .443
Thefrequency ratio ofmalignant neoplasms in Africans since the establishment ofthe
Cancer Survey Unit (Table VII)
As already mentioned above, a special cancer survey was initiated in May
1956. As a result, interest in the cancer problem grew rapidly amongst the doctors
in the city of Louren9o Marques and in the hospital. This did not affect to any
extent the number of specimens sent to the laboratory from outlying regions but
it did increase the number of histological examinations of material obtained at
operation in the hospital. The number of autopsies increased to over 80 per cent
of all patients dying in the hospital.
During the past 19 months, 210 malignant neoplasms found in Africans were
diagnosed histologically. In the male African, the liver accounted for 45 per cent,
the skin for 11-4 per cent and the urinary bladder for 8-2 per cent of all cancers.
That is to say, 64-6 per centofalltumours occurred inthese three sites. Infemales,
18 1 per cent ofcarcinomata were observed in the cervix uteri, 11-3 per cent in the
liver, 11-36 per cent in the bladder and 11L5 per cent in the skin. These tumours
represented 52 per cent of all neoplasms in African women. Up to the present,
16 carcinomata of the cervix uteri have been detected and not a single carcinoma
of the body of the uterus. Carcinoma of the oesophagus and of the lung and
bronchus were uncommon. Only 2 cases occurred in 210 malignant growths in
both sexes. Sarcoma of the jaw and other regions of the skeleton yielded 9-8 per
cent oftumours, while primary malignant neoplasms of the lymphoid tissues were
found in 9 0 per cent of cases. The frequency of carcinoma of the pancreas
remained low (0-82 per cent).
A comparison of the data collected over the 19-month period with that
accumulated over the entire previous 13 years reveals that while the frequency
ratios were not always identical, the general trend in site incidence remained
the same. Arelatively small series of 210 neoplasms collected over a period of
19 months, therefore, can yield useful suggestive informnation about the frequency
ratio of the more commonly occurring tumours.
Cancer rates in the population ofLourenfo Marques
The cancer rates survey was also initiated 19 months ago and relates to the
African population numbering approximately 100,000. One hundred and sixty-one
tumours have been studied. As previously mentioned, unless confirmed histolo-
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gically, all malignant cases diagnosed radiologically and clinically were excluded
from the above analysis.
If the maternity cases are also excluded, four times as many males were
admitted to hospital as females, indicating that some sociological factor may have
determined the male preference for seeking medical attention and admission to
TABLE V.-Ratio Survey of Malignant Neoplasms in Africans ofLourengo Marques
from May 1956-December 1957
No.
Int.
Nom. Site Type
141 . Tongue . Ca.
142.1 . Salivary
gland
144 . Mouth
153A . Large
intestine
155A . Liver .
157 . Pancreas
158 . Abdominal
cavity
161 . Larynx
162C . Lung and
bronchus
170 . Breast
171 Cervix uteri
175A . Ovary . Sarcoma
176 . Vagina . Ca.
177 . Prostate
179B . Penis
180 Kidney
Sarcoma
181 . Bladder . Ca.
190 . Skin . Malignant
melanoma
191A ,, . Basal cell ca.
191B . ,, . Miscellaneous
ca.
191D . ,, . Kaposis
192C . Eye . Ca.
Sarcoma
193A . Brain Glioma
194 . Thyroid gland . Ca.
196 . Jawbone Sarcoma
196C . Other bones ,
197 Connective .
tissue
198 . Lymph nodes Secondary ca.
200.0 Various sites . Reticulo-
endothelial
sarcoma
200.1 . ,, . Lympho-
sarcoma
201 . Ly-mph nodes . Hodgkin's
disease
203 . Bones . Myeloma
204B . Blood . Lymphatic
leukaemia
204E ,, . Myeloid
leukaemia
Male Female
, - , Total Per-
Actual Actual M. centage
number % number % and F. M. andF.
1
0
1
1
55
1
0
2
2
0
0
0
0
1
1
1
0
10
1
4
6
3
1
1
3
0
8
4
1
2
2
4
3
0
1
2
0 82 . 0
0 1
0 82 . 1
0-82 . 0
45 06 . 10
0 82 . 0
0 2
1-64 . 0
1-64 . 0
0 . 10
0 . 16
0 . 1
0 . 3
0-82 . 0
0-82 . 0
0-82 . 0
0 . 1
8-2 . 10
0-82 . 1
3 28 . 3
4 92 . 6
2-40 0
0-82 . 2
0-82 . 1
2-46 0
0 2
6 56 . 7
3 28 1
0-82 3
1 64 . 0
1-64 . 2
3 28
2-46
0
0-82
1-64
1
1
1
1
1
0 1
1-14 1
1 14 2
0 . 1
11-36 65
0 . 1
2-27 . 2
0 2
0 2
11-36 10
18-18 . 16
1 14 . 1
3 41 3
0 . 1
0 . 1
1.14} 2
11-36 . 20
1-14 . 2
3 41 . 7
6-80 . 12
0 3
2-27l5 1-14r
0 . 3
2-27 . 2
7 95 . 15
1-14 . 5
3 41 . 4
0 . 2
2-27 . 4
1-14
1-14
1-14
1-14
1-14
5
4
1
2
3
0 48
0 48
0.95
0 48
30 96
0 48
0 95
0 95
0.95
4 77
7 62
0 48
1 43
0 48
0-48
0 95
9 52
0 95
3 33
5 71
1-43
2 38
1-43
0.95
7 14
2 38
1-90
0.95
1.90
2-38
1-9
0-48
0-95
1-43
. 88 100 . 210 . 100
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Total . 122 100188 M. D. PRATES
hospital. While the data collected during the first 19 months of our rates survey
in a relatively small population can only afford an indication of the trends to be
expected, nevertheless, even at this early stage, it is evident that the frequency
of even the common tumours is further emphasized (Table VI). Thus, of 110
malignant neoplasms in males, 71 (64.54 per cent) were primary in the liver and
of 51 malignant neoplasms in females, 13 (25-5 per cent) were primary in the liver.
The bladder accounted for 8-18 per cent oftumours, and the skin for 7-27 per cent
in males, these sites together with the liver accounting for 71-81 per cent of all
malignant neoplasms. Again, the low frequency oflung carcinoma is noteworthy.
However, almost one-third of all cancers in women were primary in the cervix
uteri.
In general, the first 19 months ofthe intensive rates survey confirmed the trend
observed in the cancer frequency ratios in all the material obtained in the past
13 years. As the survey progresses, it may well be that the frequency ratio of
liver cancer will decline a little but, at present, there can be little doubt that
amongst males, the liver is still the most frequent site of cancer. In females
TABLE VI.-Rates Survey ofMalignant Neoplasms in Africans ofLourenfo Marques
from May 1956-December 1957
No.
Int.
Nom. Site
142.1 Salivary gland
Parotid
144 . Mouth
151 . Stomach
153A . Large
intestine
155A . Liver
146 . Nasopharynx
170 . Breast
171 . Cervix uteri
176 . Vulva
177 . Prostate
179B . Penis
180 . Kidney
181 . Bladder
190 . Skin
191A,B ,,
191D ,
192C . Eye
193A . Brain
194 . Thyroid gland
196 . Jawbone
197 . Connective
tissue
200.1 . Various sites
201 . Lymph nodes
204A . Blood
Male
Actual
Type number %
Ca. 0 0
71
1
. ~~71
,, . ~~~1
0
0
0
4
3
Various 1
neoplasms
Ca. . 9
Melano- . 2
blastoma
Ca. 5
Kaposi 1
Ca. I 1
Sarcoma . 0
Glioma . 3
Ca. . 0
Sarcoma . 1
Adamantinoma . 1
Sarcoma . 1
Lymphosarcoma . 1
Hodgkin's . 0
disease
Myeloid 2
leukaemia
T51 100 . 161 100
Female
Actual
number %
1 1-96
0-91
0-91
0-91
64- 54
0-91
0
0
0
3-63
2-73
0-91
8-18
1-82
4-54
0-91
0-91
0
2-73
0
0-91
0-91
0-91
1-96
0
0
25-5
0
1-96
29-42
1*96
0
0
1-96
7-84
0
3-92
0
} 3-92
3-92
3-92
0
0
3-92
Total
M.
and F.
1
2
1
1
84
1
1
15
I
4
3
2
13
2
7
1
3
3
2
2
3
2
1
4
0
0
13
0
1
15
0
0
1
4
0
2
0
1
1
2
2
0
0
2
2
Per-
centage
M. and F.
0-62
1-24
0-62
0-62
. 52-17
0-62
0-62
9-31
0-62
2-48
1-85
1-24
8-07
1-24
4-44
0-62
1-85
3-10
1-24
1-24
1-85
1-24
0-62
2-48
0-91
0
1-82
1-96
1-96
3-92
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carcinoma ofthe cervix occurs more frequently than all other cancers, with cancer
ofthe liverranking next in order ofimportance and this despite the smallernumber
of women seeking hospital treatment. Both in males and females, cancer of the
bladder is equally common, being second in order offrequency in males and third
in the females. It is hoped that when the cancer rates survey is completed, it will
be possible to know, with greater confidence whether carcinoma of the stomach,
oesophagus, breast and lung are indeed lower in the African in Louren,o Marques,
as the frequency ratio study seems to suggest. However, there is sufficient
information to show that primary cancer of the liver is a particular problem in
Lourenvo Marques and justifies an intensive study into the aetological factors.
Comparison of cancer frequency ratios in Mozambique with that in other parts of
Africa
With the exception of Kampala (1952-53) and Durban (1950-56), carcinoma
of the liver in male Africans is the commonest tumour in all cancer surveys thus
far reported from Johannesburg, Mozambique, Belgian Congo and Nigeria and
reaches the highest frequency ratio in Louren,o Marques where liver carcinoma
is twice as common as in Johannesburg and three times as common as in Kampala.
It is ofinterest to note that Findlay (1940-45) reported 60 tumours in West African
soldiers aged 18 to 40 years and of these 37 were primary cancer of the liver.
Moreover, calculations made from the data presented by Elmes and Baldwin
(1947) for Nigeria reveal a frequency ratio of 11 9 per cent for primary carcinoma
of the liver.
The frequency ratio of carcinoma of the skin ranges from 11-2 to 16-3 per cent
and is the commonest cancer in Kampala and Durban, second in order offrequency
in Mozambique and Johannesburg (Higginson and Oettle, 1958, personal com-
munication) and third in the Stanleyville and in the data submitted by Berman
(1935) for Johannesburg. Tumours of the bladder constitute between 4 and 8 per
cent of all neoplasms in Mozambique, Johannesburg and Kampala but less than
1 per cent in Stanleyville. In Mozambique, bladder tumours are almost twice as
frequent as in Johannesburg and Kampala.
The relatively high frequency ratio of carcinoma of the lung and bronchus in
Johannesburg (7.7 per cent) (Higginson and Oettle, 1958, personal communica-
tion) and in Durban (7.7 per cent) contrasts with the lower frequency of tumours
of this organ in Kampala (1.95 per cent) and the rarity of this tumour in Mozam-
bique (less than 1 per cent) and in Dakar (Camain, 1954). Similarly, the high
frequency ratio of carcinoma of the rectum in Johannesburg (8.0 per cent) differs
from the lower frequency in Kampala (2.3 per cent) and the still lower frequency
ratio (less than 1 per cent) in Mozambique and Stanleyville. Apparently, tumours
of the gastro-intestinal tract are more common in Johannesburg and Kampala
than in Mozambique and Stanleyville. The frequency of carcinoma of the penis
appears to be considerably higher in Kampala (10-0 per cent) than in any other
African territory (1-4 per cent).
Females.-The high frequency ratio of carcinoma of the cervix is a feature of
all reports from Africa with the exception of Dakar. In Nigeria, tumours of the
uterus ranked second in order offrequency.
Skin tumours were found first in order of frequency in Durban and second in
Johannesburg (12.1 per cent) and Stanleyville (13.2 per cent) and third in Mozam-
bique (13.9 per cent in both sexes). In Kampala, skin tumours constituted only
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8 per cent of all tumours and only 3 per cent in the figures pul lished by Berman
(1935) for Johannesburg.
The frequency ratio of liver carcinoma in African females was only slightly
higher (14-6 per cent) than that of skin carcinoma (13.8 per cent) in Mozambique
and was at least twice as high as the frequency ratio of liver carcinoma in Johan-
nesburg (Higginson and Oettle (6.0 per cent), Berman (5.0 per cent), Stanleyville
(45 per cent) and Kampala (4.1 per cent). Carcinoma of the liver was consistently
lower amongst females than in males in all the surveys presented in Tables VII
and VIII.
The frequency ratio of breast tumours was variable. Whereas breast carci-
noma constituted 7-4 and 9 0 per cent of all tumours in Mozambique and Kampala
respectively, the percentage frequency was 11-3 and 12-0 per cent in Johannesburg
(Higginson and Oettle) and Stanleyville (Thijs, 1957) and 25-3 and 21-4 per cent
in Johannesburg (Berman, 1935) and Nigeria respectively. Squamous cell car-
cinoma of the vagina was consistently higher in Mozambique (5.5 per cent) than
elsewhere while tumours of the ovary appeared to be unusually high in Stanley-
ville (8-8 per cent) and in Kampala (11.5 per cent). Carcinoma of the gastro-
intestinal canal was unusual and involved mainly the stomach, the highest fre-
quency ratio being reported in Johannesburg by Berman. Carcinoma of the
rectum occurred in less than 1 per cent oftumours in all surveys, except in Kampala.
Except in Durban (Wainwright and Roach, 1957) cancer of the lung and bronchus
comprised 1-4 per cent or less of all tumours in females in all the surveys
reported.
As in the African male, carcinoma of the bladder was high (7.9 per cent) in
African females in Mozambique but was far less frequent in the other African
territories. Camain (1954) from Dakar, reported on 1884 malignant neoplasms in
Africans over an 11-year period. Unfortunately, he did not separate the sexes
and therefore it is not possible to compare the Lourengo Marques tumours with
those in Dakar. However, Camain does mention that two-thirds of the tumours
were obtained from males and one-third from females. It would appear that the
frequency ratio of primary liver cancer in Dakar is a little lower than in Louren,o
Marques. Noteworthy in Dakar, as in Lourenco Marques, are the low frequency
ratios of pancreatic, large bowel, lung and breast cancers. The ratio of cancer of
the body to cancer of the cervix uteri in Dakar is as 1: 5-7, which contrasts with
the reported ratios from other parts of Africa.
From this comparative survey, whatever the limitations thereof, it is evident
that in several territories south of the Sahara, primary liver cancer is the pre-
dominant malignant neoplasm in males, the only anomalous report being from
Kampala. With the exception of Dakar and possibly also of Nigeria, carcinoma of
the cervix uteri in females ranks first in importance amongst all neoplasms in
African women. Both in males and in females, primary carcinoma of the liver,
bladder and skin show a markedly higher frequency ratio in Mozambique than
elsewhere in Africa. With the exception of Johannesburg and Kampala, carci-
noma of the gastro-intestinal canal amongst Africans appears to be infrequent.
At present, cancer of the lung and bronchus does not appear to be a problem of
any significance amongst African females and, with the exception ofJohannesburg,
these tumours are also uncommon in African males.
The comparative analysis of the tumour frequency ratio reveals that primary
liver cancer in males and cancer of the bladder in both sexes in Lourenco Marques
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TABLE VII.-Order of Frequency of Malignant Neoplasms in African Males in
Different Parts ofthe Continent ofAfrica t
Site
Skin
Stomach
Colon
Larynx
Lung and bron-
chus
Hodgkin's disease
Sarcoma
Lymph nodes
Rectum
Prostate
Lip
Liver
Brain
Tongue
Bones
Mouth
Gall bladder
Testis
Louren9o Marques
1944-57 (Prates)
Europeant
Total % Sit
91 30-0 Liver
27 8-9 Skin
17 5-6 Lymphom
15 4- 9 Bladder
14 4- 6 Sarcoma
Penis
12 3 9 Kaposi's t
10 3- 3 Bones
10 3- 3 Eye
10 3
- 3 Lymph no
10 3- 3 (secondE
8 2- 6 Brain
8 2- 6 Mouth
8 2-6 Prostate
5 1-6 Stomach
5 1-6
4 1-3
4 1-3
4 1-3
African
te Total %
363 43-1
117 13-9
Lata . 73 8-6
. 67 7-9
. 46 5-5
29 3-4
tumour. 22 2-6
. 20 2-3
. 17 2-0
odes:
ary) . 15 1-7
. 14 1-6
13 1-5
10 1-2
9 1-0
Johannesburg
1926-33 (Berman)
Site Total %
Liver . 36 31-0
Stomach . 17 14-7
Skin . . 13 11-2
Bladder . 5 4-3
Lip . . 5 4-3
Penis . . 4 3-4
Pancreas . 4 3-4
Bones . . 4 3-4
Prostate . 3 2-6
Rectum . 3 2- 6
Tongue . . 3 2-6
Mouth . 2 1-7
Nasal sinuses . 2 1-7
Lung and bron- 2 1-7
chus
Colon . 2 - 1-7
Lymph nodes . 2 1-7
Johannesburg
1953-55 (Higginson and Oettle)
Rural, 1953-55
Site Total %
Liver . 36 20-5
Skin . . 25 14- 2
Rectum . . 14 8-0
Lung and bron- 13 7-4
chus
Bones . . 11 6-3
Prostate . . 8 4-5
Bladder . . 8 4-5
Sinuses . . 6 3- 4
Leukaemia . 6 3-4
Lymphomata . 6 3-4
Kaposi's tumour 5 2-8
Salivary gland . 5 2-8
Oesophagus . 4 2-3
Stomach . 4 2-3
Kidney . 4 2-3
Mouth . . 3 1-7
Testis . . 3 1-7
Pancreas . . 2 1- 1
Larynx . . 2 1-1
Breast . 2 1-1
Eye . . . 2 1-1
Penis and scrotum 2 1- 1
Stanleyville
1939-55 (Thijs)
Site Total %
Reticulo-endothe- 190 16-3
lial tumours
Liver . . 185 16-0
Skin . . . 179 15-5
Kaposi's tumour. 155 13-3
Sarcoma . . 68 5-9
Penis . . 45 3-8
Salivary gland . 33 2-9
Stomach . . 19 1-6
Eye . 19 1-6
Breast . . 18 1-5
Testis . 12 1-0
Scrotum - . 12 1-0
Urban, 1953-55
Site Total %
Liver . . 114 22-0
Oesophagus 53 10-2
Stomach . . 41 7- 9
Lung and bron- 40 7-7
chus
Hodgkin's disease 27 5-4
Prostate . . 21 4-0
Lymph nodes:
(secondary) . 20 3-8
Leukaemia . . 18 3-4
Mouth . . 18 3-4
Bladder . . 17 3-2
Salivary gland . 15 2-8
Brain . . 14 2-7
Skin . . . 14 2-7
Kaposi's tumour . 11 2-1
Pancreas . . 10 1-9
Penis and scrotum 9 1-7
Sinuses . . 9 1-7
Larynx . . 8 1-5
Colon . . 7 1-3
Bones . 6 1-1
Kampala
1952-53 (Davies)
Site Total
Skin. . . 69
Liver . . 43
Penis . . 42
Bladder . 20
Prostate . . 19
Stomach . . 19
Colon . . 15
Eye. . .13
Oesophagus . 11
Rectum - . 10
Lung and bron- 8
chus
Pancreas . 5
16-3
10-1
10-0
4-7
4-5
4-5
3-5
3-0
2-6
2-3
1-9
1.1
Durban
1950-56 (Wainwright)
Site Total %
Skin* . 271 14-1
Liver* . . 128 7-2
Oesophagus* 119 6-1
Lung and bron- 89 4-5
chus*
Prostate . . 63 3-2
Bladder* . 54 2-8
Penis 54 2-8
Mouth, tongue* . 50 2-5
Stomach* . 44 2-2
Naso-pharynx* 44 2-2
Intestine, colon* 38 1-9
Kaposi's tumour* 25 1-3
Nigeria
1935-44
(Elmes and Baldwin)
Site Total %
Liver . . 57 11-9
Kaposi's tumour. 22 4- 6
Stomach . . 13 2-7
Penis . . 10 2-1
Prostate . 8 1-7
Breast . . 7 1-5
Testis . . 7 1-5
Scrotum 5 1-0
t Tumours less than 1v0 per cent are not included in this table.
t Europeans from Louren9o Marques included for comparison.
* Denotes both sexes.
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TABLE VIII.-Order of Frequency of Malignant Neoplasms in African Females in
Different Parts of the Continent of Africa t
Lourenco Marques
Europeant African
Site Total % Site Total %
Breast . . 66 23 8 Cervix uteri . 89 20-6
Cervix uteri . 55 19-8 Liver . . 63 14-6
Skin . . 42 15<1 Skin . . 60 13 9
Corpus uteri . 14 5 0 Breast . . 32 7-4
Stomach . 13 4- 7 Bladder . . 31 7 - 2
Sarcoma . . 13 4- 7 Lymphomata . 25 5- 8
Chorion-epithe- 10 3 6 Vagina . 24 5-5
lioma Eye . . 19 4-4
Ovary . 9 3.2 Sarcoma . 15 3-4
Gall bladder . 7 2-5 Bones . . 11 2-5
Vagina . 6 2<1 Mouth . 9 2-1
Colon . 6 2-1 Lip . . 7 1b6
Hodgkin's disease 6 2 1 Thyroid . . 6 1-4
Small intestine . 3 1-0 Ovary . . 5 1.1
Liver . . 3 1-0 Salivary gland . 5 1.1
Lymph nodes:
(secondary) . 3 1-0
Johannesburg
1953-55 (Higginson and Oettl6)
Rural, 1953-55 Urban, 1953-55
Site Total % Site Total %
Cervix uteri . 68 27-4 Cervix uteri . 198 41-6
Skin . . 30 12-1 Breast . . 50 10-5
Breast . 28 11-3 Liver . . 25 5-2
Liver . 15 6 0 Ovary . 19 4-0
Bones . 14 5-6 Stomach . 17 3-5
Salivary gland . 12 4-8 Leukaemia. 16 3-3
Corpus uteri . 9 3-6 Lymphomata 16 3-3
Lymphomata 9 3-6 Lymph nodes:
Stomach . . 8 3-2 (secondary) . 13 2- 7
Sinuses . . 7 2- 8 Brain . 12 2- 5
Ovary . . 5 2-0 Skin . . . 12 2-5
Bladder . . 5 2-0 Salivary gland . 12 2-5
Adamantinoma . 4 1-6 Large intestine . 9 1-8
Kidney . . 4 1-6 Thyroid . 7 1 4
Eye . . 4 1- 6 Lung and bron- 7 1-4
Pharynx . . 3 1-2 chus
Vulva . 3 1-2 Rectum . 6 1-2
Leukaemia . 3 1-2 Chorion- 5 1-0
epithelioma
Stanleyville
1939-55 (Thijs)
Site Total %
Cervix uteri 162 17.9
Skin . . . 120 13-2
Breast . 109 12-0
Ovary . . 77 8-8
Reticulo-endo- 67 7.4
thelial tumours
Sarcoma . . 44 4.9
Salivary gland . 41 4- 5
Liver . 41 4- 5
Vulva . . 27 2-9
Kaposi's tumour. 18 1-9
Stomach . 14 1- 5
Eye . . . 13 1-4
Corpus uteri . 11 1-2
Chorion-epithe- 10 1-1
lioma
Mouth . . 9 1-0
Kampala
1952-53 (Davies)
Site Total %
Cervix uteri 58 18-5
Ovary . . 36 11-5
Breast 28 9-0
Skin . . 25 8-0
Corpus uteri 19 6-0
Liver . . 13 4-1
Colon . 11 3-5
Oesophagus . 6 2-0
Rectum . 6 2-0
Eye . . . 6 2-0
Stomach . . 5 1-6
Vagina . 4 1-2
Vulva . 4 1 -2
Thyroid . 4 1-2
Salivary gland 1 1-2
Johannesburg
1926-33 (Berman)
Site Total %
Cervix uteri . 27 27-3
Breast . . 25 25-3
Corpus uteri 15 15-2
Ovary . . 6 6-1
Stomach . 6 6-1
Liver . . 5 5-0
Skin. . . 3 3-0
Thyroid . . 3 3-0
Lip . . 1 1-0
Salivary gland . 1 1-0
Colon . 1 1-0
Rectum . 1 1-0
Pancreas . . 1 1.0
Nose . . 1 1-0
Vulva . . 1 1-0
Kidney . 1 1-0
Lymph nodes . 1 1-0
Durban
1950-56 (Wainwright)
Site Total %
Cervix uteri . 374 19-2
Skin* . . 271 14-1
Liver* . 128 7-2
Oesophagus* 119 6-1
Breast . 113 5-8
Lung and bron- 89 4-5
chus*
Bladder* . 54 2- 8
Mouth, tongue* . 50 2-5
Stomach* 44 2- 2
Nasopharynx* . 44 2-2
Intestine, colon* . 38 1-9
Ovary . . 30 1-5
Vulva . . 25 1-3
Kaposi's tumour * 25 1-3
Nigeria
1935-44
(Elmes and Baldwin)
Site Total %
Breast . . 77 21 4
Uterus . . 68 16-4
Ovary . . 20 5-5
Chorion-epithe- 9 2-5
lioma
Vulva . . 7 1-9
Vagina . . 5 1e4
Stomach . . 5 1e4
t Tumours less than 1-0 per cent are not included in this table.
t Europeans from Louren9o Marques included for comparison.
* Denotes both sexes.
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are more frequent than in any other part of Africa from which information is
available. Furthermore, having regard to the imperfections of the statistical
information, there is more than suggestive evidence that liver cancer in males
and primary carcinoma of the cervix in females still constitute a pan-African
problem in such remotely separated regions as Kampala and Johannesburg. The
surprisingly high frequency ratio of cancer of the stomach in African males in
Johannesburg and of carcinoma of the oesophagus, bronchus and lungs in males
in Johannesburg and Durban suggest that an environmental rather than a genetic
factor is at play in the aetiology of these cancers.
Although there are many features in common in the frequency ratio of cancer
in various parts ofAfrica, there is also sufficient diversity to suggest that selection
of specific areas for more intensive study might provide much valuable informa-
tion about the possible aetiological factors responsible for the difference in the
susceptibility to cancer of the various organs of the body. In view of the rapidly
changing socio-economic conditions in Africa, it is urgent that aetiological studies
be initiated without delay lest the opportunity be lost ofprobing the aetiology of
those types of tumours which are afflicting populations not only in the western
world but also in Africa and in Asia.
SUMMARY
An analysis has been presented of 1977 malignant neoplasms diagnosed at
autopsy and by histological examination and accumulated over a period of 13
years in the Province ofMozambique, Portuguese East Africa. Ofthese tumours,
1273 were derived from Africans, 580 from Europeans and 124 from other ethnic
groups.
Attention was drawn to the high frequency ratio of carcinoma of the liverin
Africanmales and to thefactthat 73-5per centofallmalignant neoplasms occurred
in four sites, namely, the liver (43.1 per cent), the skin (13.9 per cent), lymphoid
tissues (8.6 per cent) and urinary bladder (7.9 per cent). Carcinoma of the oeso-
phagus, stomach, colon and rectum, lung and bronchus were remarkably low in
the African as compared with European males living in Mozambique. Carcinoma
of the cervix uteri was the commonest tumour (20-6 per cent) in African females
and together with carcinoma ofthe liver (14.6 per cent), skin (13.9 per cent), and
bladder (7.2 per cent) was responsible for 56-3 per cent ofall malignancies as com-
pared with 36-6 per cent of tumours in comparable sites in European females.
Noteworthy was the high frequency of cervical carcinoma as compared with car-
cinoma ofthe body ofthe uterus and the relatively low frequency ofbreast cancer (7.4 per cent) in African females.
This analysis disclosed that primary carcinoma ofthe liver was occurring with
unusual frequency in young people although the age ofmaximum incidence could
not be established before completion ofthe rates survey now in progress.
It became evident that in the absence ofwell established cancerregistries, data
accumulated from the hospital and routine pathology laboratory could provide a
useful guide to the frequency ratio of various cancers in Africa. From a com-
parison of the data compiled in Louren9o Marques with that derived from other
African territories, it was apparent (1) that amongst African males, primary liver
cancer and in females, carcinoma of the cervix uteri, with two exceptions were
the mostfrequently occurring malignant neoplasms and (2) thattherewerenotable
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differences in the frequency ratios of malignant neoplasms in different regions in
Africa. The urgency forinitiating aetiological studies to explore the basis for these
differences was emphasized.
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